1. Home
  2. VYNE vs PETZ Comparison

VYNE vs PETZ Comparison

Compare VYNE & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • PETZ
  • Stock Information
  • Founded
  • VYNE 2003
  • PETZ 2002
  • Country
  • VYNE United States
  • PETZ China
  • Employees
  • VYNE N/A
  • PETZ N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • PETZ Steel/Iron Ore
  • Sector
  • VYNE Health Care
  • PETZ Industrials
  • Exchange
  • VYNE Nasdaq
  • PETZ Nasdaq
  • Market Cap
  • VYNE 7.9M
  • PETZ 9.3M
  • IPO Year
  • VYNE 2018
  • PETZ 2017
  • Fundamental
  • Price
  • VYNE $0.30
  • PETZ $1.02
  • Analyst Decision
  • VYNE Buy
  • PETZ
  • Analyst Count
  • VYNE 2
  • PETZ 0
  • Target Price
  • VYNE $8.00
  • PETZ N/A
  • AVG Volume (30 Days)
  • VYNE 1.9M
  • PETZ 4.4K
  • Earning Date
  • VYNE 11-06-2025
  • PETZ 04-28-2025
  • Dividend Yield
  • VYNE N/A
  • PETZ N/A
  • EPS Growth
  • VYNE N/A
  • PETZ N/A
  • EPS
  • VYNE N/A
  • PETZ 0.26
  • Revenue
  • VYNE $476,000.00
  • PETZ $563,726.00
  • Revenue This Year
  • VYNE N/A
  • PETZ N/A
  • Revenue Next Year
  • VYNE N/A
  • PETZ N/A
  • P/E Ratio
  • VYNE N/A
  • PETZ $4.99
  • Revenue Growth
  • VYNE N/A
  • PETZ 74664.72
  • 52 Week Low
  • VYNE $0.29
  • PETZ $0.65
  • 52 Week High
  • VYNE $4.30
  • PETZ $1.74
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 28.46
  • PETZ 51.12
  • Support Level
  • VYNE $0.32
  • PETZ $1.02
  • Resistance Level
  • VYNE $0.33
  • PETZ $1.10
  • Average True Range (ATR)
  • VYNE 0.02
  • PETZ 0.04
  • MACD
  • VYNE 0.03
  • PETZ 0.00
  • Stochastic Oscillator
  • VYNE 11.44
  • PETZ 33.33

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About PETZ TDH Holdings Inc.

TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.

Share on Social Networks: